# HbA1c Variability in Type II Diabetes

> **NCT02879409** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Weill Cornell Medical College in Qatar** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Metformin
- **DRUG:** Gliclazide
- **DRUG:** Sitagliptin
- **DRUG:** Liraglutide
- **DRUG:** Pioglitazone
- **DRUG:** Dapagliflozin
- **DRUG:** human insulin

## Key facts

- **NCT ID:** NCT02879409
- **Lead sponsor:** Weill Cornell Medical College in Qatar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11
- **Primary completion:** 2023-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02879409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02879409, "HbA1c Variability in Type II Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02879409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*